Cellumen to Build CHDI-funded Systems Cell Biology Model of Huntington s Disease | GenomeWeb

NEW YORK, Feb.24 (GenomeWeb News) - In an agreement with non-profit CHDI, Cellumen will build a cellular model of Huntington's disease as the foundation of neurotoxicity profiling panel to characterize pre-clinical candidate models, Cellumen said yesterday.

The collaboration is expected to last about a year, Robert Pacifici of CHDI told GenomeWeb News.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.